Hui-Li Wang Selected Research

Hui-Li Wang Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2020
3	Neoplasms (Cancer) 09/2019 - 06/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2021 - 06/2009
2	Inflammation (Inflammations) 05/2021 - 01/2018
2	Adenocarcinoma of Lung 09/2019 - 01/2018
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2015 - 02/2014
2	Body Weight (Weight, Body) 09/2013 - 06/2010
1	Non-alcoholic Fatty Liver Disease 07/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2022
1	Obesity 07/2022
1	Disease Progression 01/2022
1	Dysbiosis 01/2022
1	Infections 10/2021
1	Mastitis 05/2021
1	Optic Atrophy 04/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	Sleep Deprivation 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019
1	Iron Deficiencies 01/2019
1	Mouth Neoplasms (Oral Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Carcinogenesis 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2017
1	Cognitive Dysfunction 01/2017
1	Sepsis (Septicemia) 12/2016
1	AIDS-Related Complex (ARC) 01/2016
1	Cardiomyopathies (Cardiomyopathy) 08/2014
1	Nervous System Diseases (Neurological Disorders) 02/2014
1	Chronic Pain 09/2012
1	Pain (Aches) 09/2012
1	Melanoma (Melanoma, Malignant) 06/2010
1	Experimental Melanoma 06/2010
1	Skin Neoplasms (Skin Cancer) 06/2010
1	Mood Disorders (Mood Disorder) 05/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2014
3	IronIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 05/2021 - 06/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 09/2019 - 01/2018
2	Histones (Histone)IBA 05/2015 - 02/2014
1	LipidsIBA 07/2022
1	bisphenol AIBA 07/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	FlavonoidsIBA 05/2021
1	EnzymesIBA 05/2021
1	Caspase 3 (Caspase-3)IBA 05/2021
1	dihydromyricetinIBA 05/2021
1	RotenoneIBA 10/2020
1	Dynamins (Dynamin)IBA 04/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	CannabinoidsIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	trioctyl trimellitate (TOTM)IBA 01/2020
1	RimonabantIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 09/2019
1	Tyrosine Kinase InhibitorsIBA 09/2019
1	TOR Serine-Threonine KinasesIBA 09/2019
1	Angiogenesis InhibitorsIBA 01/2018
1	Cyclin D1IBA 01/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2018
1	MelatoninIBA 01/2018
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	OvalbuminIBA 01/2018
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2018
1	VimentinIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	AntioxidantsIBA 01/2017
1	LipopolysaccharidesIBA 12/2016
1	ORALIT (ORS)IBA 12/2016
1	Toll-Like Receptor 4IBA 12/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	asaroneIBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	Uncoupling Protein 2IBA 08/2014
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 09/2013
1	Formaldehyde (Formol)FDA Link 09/2012
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 09/2012
1	azasteneIBA 09/2012
1	Morphine (MS Contin)FDA LinkGeneric 09/2012
1	arsenic disulfide (realgar)IBA 06/2010
1	EstersIBA 06/2009
1	ethyleneIBA 06/2009
1	Vitamin E FDA LinkGeneric 06/2009
1	AcidsIBA 06/2009
1	Serine (L-Serine)FDA Link 05/2007

Therapy/Procedure

1	Oral Administration 07/2022
1	Transplantation 01/2022
1	Intraperitoneal Injections 01/2020
1	Length of Stay 04/2017
1	Therapeutics 02/2014
1	Analgesia 09/2012